Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2022-04-21 | 2022-08-20 | 159210 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-11-14 | 2023-02-02 | 174604 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-12-22 | 2023-04-28 | 179297 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-21 | 190686 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2023-06-08 | 2023-06-27 | 194097 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2023-06-16 | 2023-06-27 | 195201 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-07-23 | 2020-08-21 | 120887 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-08-20 | 2020-10-08 | 122705 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-09-24 | 2020-10-08 | 124989 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128019 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-08-08 | 2024-11-01 | 234882 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2024-09-05 | 2024-11-01 | 236808 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-18 | 131075 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-25 | 131084 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-02-18 | 2021-03-04 | 134337 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-03-11 | 2021-03-25 | 135567 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-03-11 | 2021-03-18 | 135570 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-10-07 | 2021-11-11 | 146853 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Actual shortage | 2025-03-13 | 2025-04-24 | 252578 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Actual shortage | 2025-03-13 | 2025-05-08 | 252581 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |